Zoono Group Ltd (ASX: ZNO) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Zoono Group Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $16.50 million
P/E Ratio 28.90
Dividend Yield 0.00%
Shares Outstanding 419.11 million
Earnings per share -0.004
Dividend per share 0.03
Year To Date Return -39.57%
Earnings Yield 3.46%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Zoono Group Ltd (ASX: ZNO)
    Latest News

    Biotechnology graphics
    ASX Share Market News

    3 ASX biotech shares that have soared higher today

    The ASX is home to a small but vibrant and growing biotechnology sector. Here we look at 3 ASX biotech…

    Read more »

    a woman
    Coronavirus News

    How this small cap ASX biotech company is helping the fight against coronavirus

    ASX biotech company Zoono Group Ltd (ASX: ZNO) has developed a skin and surface sanitiser spray that kills coronavirus and…

    Read more »

    a woman
    Technology Shares

    Why you should add this ASX tech share to your 2020 watchlist

    The share price of ASX software company Objective Corporation Limited (ASX:OCL) has rallied 30% over the past few weeks. Here’s…

    Read more »

    a woman
    Coronavirus News

    Coronavirus: Why this small cap ASX biotech share jumped 12% higher

    The Zoono Group Ltd (ASX:ZNO) share price jumped 125 higher on Wednesday. Here's why the biotech share is benefiting from…

    Read more »

    a woman
    ASX Share Market News

    Here's why the Zoono share price zoomed 13% higher today

    The Zoono Group Ltd (ASX: ZNO) share price is soaring higher today after a business update on its performance so…

    Read more »

    a woman
    ASX Share Market News

    Why this small-cap ASX healthcare share surged 24% today

    The Eagle Health Holdings Ltd (ASX:EHH) share price opened 24.32% higher today on news it is expanding production of disposable medical…

    Read more »

    a woman
    Share Gainers

    These ASX shares are fighting the spread of coronavirus

    Some ASX shares are fighting coronavirus with demand for their products accelerating along with the spread of the virus. We…

    Read more »

    a woman
    ASX Share Market News

    Why the Zoono share price has skyrocketed 250% in 2020

    Zoono Group Limited (ASX: ZNO) has become an unlikely leader in the global fight against the spread of coronavirus.

    Read more »

    a woman
    ASX Share Market News

    Why the Zoono share price rocketed another 19% higher today

    Here's why the Zoono Group Ltd (ASX: ZNO) share price has rocketed another 19.26% today to close at $2.26.

    Read more »

    a woman
    Share Gainers

    Why Amaysim, Freedom Foods, NEXTDC, & Zoono are pushing higher

    NEXTDC Ltd (ASX:NXT) and Zoono Group Ltd (ASX:ZNO) shares are two of four defying the market selloff and pushing higher…

    Read more »

    a woman
    Coronavirus News

    Zoono share price rockets 28% on coronavirus test results

    The Zoono Group Ltd (ASX:ZNO) share price is rocketing higher after the company announced successful test results against the coronavirus.

    Read more »

    a woman
    ASX Share Market News

    These 3 ASX healthcare shares could make you rich

    Here are 3 ASX healthcare shares looking to carve out their own niches – and in doing so, might even…

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    04 Sep 2020 $0.0300 0.00% Final 21 Sep 2020

    ZNO ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Zoono Group Ltd

    Zoono Group Ltd. is a pharmaceutical and biotechnology company. The firm is engaged in the development, manufacture, and sale of antimicrobial technology effective against all pathogens including bacteria, viruses, mould, algae, and fungi. Its products include aerosol-based sprays, surface sanitizers, treatment of acne, and mould remediation. The company was founded on October 8, 1986 and is headquartered in Auckland, New Zealand.

    ZNO Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    29 Oct 2026 $0.05 $0.00 0.00% 274 $0.05 $0.05 $0.05
    28 Oct 2026 $0.05 $0.00 0.00% 9,039 $0.05 $0.05 $0.05
    27 Oct 2026 $0.05 $0.00 0.00% 21,247 $0.05 $0.05 $0.05
    23 Oct 2026 $0.05 $0.00 0.00% 172,000 $0.04 $0.05 $0.04
    21 Oct 2026 $0.05 $0.00 0.00% 317,664 $0.04 $0.05 $0.04
    20 Oct 2026 $0.04 $0.00 0.00% 478,755 $0.05 $0.05 $0.04
    19 Oct 2026 $0.05 $0.01 26.73% 652,799 $0.04 $0.05 $0.04
    16 Oct 2026 $0.04 $-0.01 -21.61% 100,000 $0.04 $0.04 $0.04
    14 Oct 2026 $0.05 $0.00 0.00% 28,287 $0.05 $0.05 $0.05
    12 Oct 2026 $0.05 $0.00 0.00% 246,096 $0.05 $0.05 $0.05
    09 Oct 2026 $0.05 $0.00 0.00% 8,019 $0.05 $0.05 $0.05
    08 Oct 2026 $0.05 $0.00 0.00% 34,126 $0.05 $0.05 $0.05
    07 Oct 2026 $0.05 $0.00 0.00% 4,706 $0.05 $0.05 $0.05

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    25 Sep 2026 Marc Braterman Sell 782,022 $39,101
    Off-market trade.
    24 Sep 2026 Donald Clarke Buy 260,674 $13,033
    Off-market trade.
    24 Sep 2026 Paul Hyslop Expiry 4,963,167 $243,195
    Options expired.
    24 Sep 2026 Donald Clarke Expiry 22,500 $1,102
    Options expired.
    24 Sep 2026 Paul Hyslop Buy 260,674 $13,033
    Off-market trade.
    24 Sep 2026 Elissa Hansen Buy 260,674 $13,033
    Off-market trade.
    24 Sep 2026 Elissa Hansen Expiry 22,250 $1,090
    Options expired.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Donald Ian Clarke Non-Executive Director Apr 2017
    Mr Clarke was a Partner of Minter Ellisons Melbourne Corporate Group from 1988 until 2015. He is currently a consultant to the firm. He has advised leading corporate clients on broad corporation law issues focused on equity capital markets, private equity, mergers and acquisitions and corporate restructures. He is able to draw on his first hand experience as a corporate lawyer and a company director in guiding the Company and the Board on the duties and responsibilities of the Directors and the best practice in corporate governance.
    Ms Elissa Hansen Company SecretaryNon Executive Director Aug 2015
    Ms Hansen has over 20 years of experience advising boards and management on corporate governance, compliance, investor relations and other corporate related issues. She is a Chartered Secretary who brings best practice governance advice, ensuring compliance with the Listing Rules, Corporations Act and other relevant legislation.
    Mr Paul Hyslop Managing Director Apr 2017
    Mr Hyslop founded Zoono Group in 2007 to address the need for a highly effective, alternative method of combating bacteria and microbes and realised the business opportunity surrounding this technology. Prior to establishing Zoono, he was involved in several successful entrepreneurial ventures ranging from the establishment of a successful private car sales business in Auckland in 1990, to real estate development and business brokerage. He also set up a franchise business in the USA 2002 to 2005. Adept at dealing with businesses and consumers alike, he co established the Business Brokerage Division at Bayleys Real Estate one of the largest real estate and business brokerages in New Zealand, where he was twice awarded the Salesman of the Year award.
    Mr Marc Braterman Non-Executive Director Feb 2026
    Mr Braterman is the Founder and Chief Executive Officer of OSY Group Limited, a food technology company focused on innovation across the food supply chain, with an emphasis on improving sustainability, reducing waste, and enhancing product quality. Prior to founding OSY, he was an Investment Director at a UK based boutique private equity firm, where he focused on turnaround situations and high growth early stage investments across sectors including technology, manufacturing, and education. In this role, he sat on the boards of multiple portfolio companies, advising on strategy development, capital structuring, operational improvement, and governance matters. He was also responsible for assessing new investment opportunities and executing transactions, including acquisitions and growth investments
    Mr Barry Woolcott Global General ManagerChief Executive Officer Mar 2022
    -
    Paul Ravlich Chief Financial Officer
    -
    Lew MacKinnon Chief Operating Officer
    -
    Barry Woolcott Global General ManagerChief Executive Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Paul Russell Hyslop & Margaret Jane Morgan & NPT Meg Trustee Limited <Meg A/C> 119,368,572 29.39%
    BNP Paribas Noms Pty Ltd 64,284,308 15.82%
    Citicorp Nominees Pty Limited 61,931,650 15.25%
    Mrs Barbara Diane Wiersma & Mr Eelco Wiersma 17,493,204 4.31%
    BNP Paribas Nominees Pty Ltd <IB AU Noms RetailClient> 8,961,636 2.21%
    Mr Theophilos Papantoniou 6,400,620 1.58%
    Sharesies Australia Nominee Pty Limited 5,352,827 1.32%
    Lewis Andrew Craig Mackinnon 4,419,579 1.09%
    Ms Marie Tania Adams 4,237,155 1.04%
    Marissa Tacy Muirhead 4,118,889 1.01%
    Lordmax Pty Ltd <AL Fund A/C> 3,600,000 0.89%
    HSBC Custody Nominees (Australia) Limited - GSCO ECA 3,600,000 0.89%
    Ravlich Trustee Limited 2,828,023 0.70%
    Mr Joseph Ignatius D'Souza 2,385,978 0.59%
    Mr Libor Jelenek 2,300,000 0.57%
    Mr Andrew Lozynsky 2,208,500 0.54%
    Mr Ronald Duje Vela 1,951,852 0.48%
    Woolcott Investments Limited <The Woolcott Investment A/C> 1,886,792 0.46%
    Mr Eelco Wiersma & Mr Malcolm Hinman <Christchurch United A/C> 1,700,000 0.42%
    Mr Martin Hunt 1,683,694 0.41%

    Profile

    since

    Note